Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned
- PMID: 35901993
- PMCID: PMC9310434
- DOI: 10.1016/j.ajic.2022.07.019
Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned
Abstract
Background: The spread of coronavirus disease 2019 (COVID-19) in health care settings endangers patients with cancer. As knowledge of the transmission of COVID-19 emerged, strategies for preventing nosocomial COVID-19 were updated. We describe our early experience with nosocomial respiratory viral infections (RVIs) at a cancer center in the first year of the pandemic (March 2020-March 2021).
Methods: Nosocomial RVIs were identified through our infection control prospective surveillance program, which conducted epidemiologic investigations of all microbiologically documented RVIs. Data was presented as frequencies and percentages or medians and ranges.
Results: A total of 35 of 3944 (0.9%) documented RVIs were determined to have been nosocomial acquired. Majority of RVIs were due to SARS CoV-2 (13/35; 37%) or by rhinovirus/enterovirus (12/35; 34%). A cluster investigation of the first 3 patients with nosocomial COVID-19 determined that transmission most likely occurred from employees to patients. Five patients (38%) required mechanical ventilation and 4 (31%) died during the same hospital encounter.
Conclusions: Our investigation of the cluster led to enhancement of our infection control measures. The implications of COVID-19 vaccination on infection control policies is still unclear and further studies are needed to delineate its impact on the transmission of COVID-19 in a hospital setting.
Keywords: Hospital-associated transmission; Immunocompromised; Malignancy; Respiratory viruses; SARS CoV-2.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center.Am J Infect Control. 2023 Dec;51(12):1302-1308. doi: 10.1016/j.ajic.2023.08.019. Epub 2023 Oct 5. Am J Infect Control. 2023. PMID: 37804272
-
Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.PLoS Med. 2023 Jun 5;20(6):e1004240. doi: 10.1371/journal.pmed.1004240. eCollection 2023 Jun. PLoS Med. 2023. PMID: 37276186 Free PMC article.
-
First nosocomial cluster of COVID-19 due to the Delta variant in a major acute care hospital in Singapore: investigations and outbreak response.J Hosp Infect. 2022 Apr;122:27-34. doi: 10.1016/j.jhin.2021.12.011. Epub 2021 Dec 21. J Hosp Infect. 2022. PMID: 34942201 Free PMC article.
-
Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nosocomial Respiratory Viral Infections on the Leeside of the Pandemic.Respir Care. 2024 Jun 28;69(7):854-868. doi: 10.4187/respcare.11961. Respir Care. 2024. PMID: 38806219 Review.
-
Health Care-Acquired Viral Respiratory Diseases.Infect Dis Clin North Am. 2021 Dec;35(4):1055-1075. doi: 10.1016/j.idc.2021.07.007. Infect Dis Clin North Am. 2021. PMID: 34752220 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous